Control-IQ Technology in Individuals With Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2021

Primary Completion Date

August 10, 2022

Study Completion Date

August 18, 2022

Conditions
Type 2 Diabetes Treated With Insulin
Interventions
DEVICE

Control-IQ technology 1.5

"All subjects wearing the t-slim X2 insulin pump with Control-IQ technology 1.5, and wearing the Dexcom G6 sensor.~Outcomes will be analyzed overall and subgroup analysis will be performed by Group, and by baseline A1c level."

Trial Locations (3)

10029

Icahn School of Medicine at Mt. Sinai, New York

55905

Mayo Clinic, Rochester

78731

Texas Diabetes and Endocrinology, Austin

Sponsors
All Listed Sponsors
collaborator

Jaeb Center for Health Research

OTHER

lead

Tandem Diabetes Care, Inc.

INDUSTRY